Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.

JAMA : the Journal of the American Medical Association
Cristine J CooperNIAID HIV Vaccine Trials Network (HVTN) Vaccine-Induced Seropositivity (VISP) Task Force

Abstract

Induction of protective anti-human immunodeficiency virus (HIV) immune responses is the goal of an HIV vaccine. However, this may cause a reactive result in routine HIV testing in the absence of HIV infection. To evaluate the frequency of vaccine-induced seropositivity/reactivity (VISP) in HIV vaccine trial participants. Three common US Food and Drug Administration-approved enzyme immunoassay (EIA) HIV antibody kits were used to determine VISP, and a routine diagnostic HIV algorithm was used to evaluate VISP frequency in healthy, HIV-seronegative adults who completed phase 1 (n = 25) and phase 2a (n = 2) vaccine trials conducted from 2000-2010 in the United States, South America, Thailand, and Africa. Vaccine-induced seropositivity/reactivity, defined as reactive on 1 or more EIA tests and either Western blot-negative or Western blot-indeterminate/atypical positive (profile consistent with vaccine product) and HIV-1-negative by nucleic acid testing. Among 2176 participants free of HIV infection who received a vaccine product, 908 (41.7%; 95% confidence interval [CI], 39.6%-43.8%) had VISP, but the occurrence of VISP varied substantially across different HIV vaccine product types: 399 of 460 (86.7%; 95% CI, 83.3%-89.7%) adenovir...Continue Reading

References

Mar 28, 2003·The Journal of Infectious Diseases·Marta-Louise AckersJ Steven McDougal
Jul 11, 2003·The Journal of Infectious Diseases·Punnee PitisuttithumUNKNOWN Thai AIDS Vaccine Evaluation Group
Feb 3, 2005·The Journal of Infectious Diseases·Neil M FlynnUNKNOWN rgp120 HIV Vaccine Study Group
Sep 2, 2005·The Journal of Infectious Diseases·Paul A GoepfertUNKNOWN NIAID HIV Vaccine Trials Network
Jul 13, 2006·AIDS Research and Human Retroviruses·M J MulliganUNKNOWN NIH/NIAID/DAIDS HIV Vaccine Trials Network
Nov 16, 2006·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Nina D RussellUNKNOWN National Institute of Allergy and Infectious Diseases HIV Vaccine Trials Network
Nov 17, 2006·The Journal of Infectious Diseases·Barney S GrahamUNKNOWN Vaccine Research Center 004 Study Team
Nov 17, 2006·The Journal of Infectious Diseases·Punnee PitisuttithumUNKNOWN Bangkok Vaccine Evaluation Group
Aug 19, 2007·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Farley CleghornUNKNOWN 026 Protocol Team and the NIAID HIV Vaccine Trials Network
Apr 25, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Frances H PriddyUNKNOWN Merck V520-016 Study Group
Aug 30, 2008·JAMA : the Journal of the American Medical Association·John G BartlettKenneth H Mayer
Oct 4, 2008·Nature·Dan H Barouch
Nov 8, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Erin K QuirkMichael N Robertson
Nov 11, 2008·Vaccine·Paul SpearmanUNKNOWN NIAID HIV Vaccine Trials Network
Nov 13, 2008·AIDS Research and Human Retroviruses·Benjamin SilbermannOdile Launay
Nov 18, 2008·Lancet·M Juliana McElrathUNKNOWN Step Study Protocol Team
Jul 4, 2009·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Deborah A GustBrad N Bartholow
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators

❮ Previous
Next ❯

Citations

Dec 18, 2012·Clinical Investigation·James G KublinLawrence Corey
Jan 10, 2014·The Journal of Infectious Diseases·Paul A GoepfertUNKNOWN National Institutes of Allergy and Infectious Diseases HIV Vaccines Trials Network
Jun 8, 2013·Current Opinion in HIV and AIDS·Jean-Louis ExclerNina D Russell
Jun 8, 2012·Nature Medicine·Cassandra Willyard
Feb 9, 2011·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Eva Van BraeckelGeert Leroux-Roels
Feb 5, 2015·Vaccine·UNKNOWN VISR Working Group of Global HIV Vaccine EnterpriseMary Allen
Jan 1, 2014·Human Vaccines & Immunotherapeutics·Claudia SchmidtPatricia E Fast
Sep 26, 2013·The American Journal of Tropical Medicine and Hygiene·Sean C MurphyV Ann Stewart
Jan 1, 2013·Vaccines·Punnee PitisuttithumJean-Louis Excler
Apr 19, 2018·The Journal of Infectious Diseases·Lindsey R BadenUNKNOWN IPCAVD006/RV380/HIV-V-A002 Study Group
Aug 14, 2019·Journal of the International AIDS Society·Blythe AdamsonDobromir Dimitrov
Oct 7, 2020·International Journal of Environmental Research and Public Health·Masunga K IseseloAsli Kulane
Jan 30, 2021·Open Forum Infectious Diseases·Karina OganezovaLindsey R Baden

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology
Eva Van BraeckelGeert Leroux-Roels
Science Translational Medicine
Lawrence CoreyAnthony S Fauci
© 2021 Meta ULC. All rights reserved